Tag: immunotherapy
Private Law Firm to Investigate Claims on Behalf of Investors in...
It is unknown how this development will affect the ability of the company to eventually offer Viaskin Peanut as an FDA approved therapy.
ALK Starts Clinical Trial of SLIT Tablet to Treat Peanut Allergy
Sublingual Immunotherapy is administered via medications placed under the tongue.
DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin...
Viaskin Peanut demonstrated a statistically significant treatment effect with 67.0% of subjects meeting the treatment responder criteria after 12 months.
Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial
Phase 1 study amended after two cohorts show no significant adverse events.
New Blood Test Simplifies the Diagnosis of Allergies and Can Help...
Test is painless, safe, reliable and scalable.
Study Finds Microneedle Delivery Successful in Test of Peanut Allergy Immunotherapy
Study finds five-minute weekly dose of peanut protein through the skin, delivered by a novel microneedle technology, was superior in desensitizing peanut-allergic mice compared to administering the protein through a skin patch.
Safety of Viaskin Peanut Patch Therapy Improved Over 3-Year Study
Reactions decreased over study duration.
New Vaccine Approach to Treating Food Allergies Steps Forward
Allergy treatment "tricks" the immune system into reacting in a different, safer manner.
FDA Wants More Viaskin Peanut Data Resulting in Further Approval Delays
Delays mount pushing trials of modified patch.
Company Receives $1.9 Million Grant to Advance Microneedle Patch Therapy for...
Grant will allow Moonlight Therapeutics to complete pre-clinical activities and submit and IND to the FDA.
